Navigation Links
New EBRI/Commonwealth Fund Research: Enrollment in Consumer-Driven Plans Remains Low, Survey Shows
Date:3/18/2008

More than 30% Enrolled in Consumer-Driven Plans Have Household Incomes Over $100,000 a Year

WASHINGTON, March 18 /PRNewswire-USNewswire/ -- Enrollment in consumer-driven and high-deductible health plans increased in 2007, but still makes up a small segment of the overall insurance market, according to the third EBRI/Commonwealth Fund Consumerism in Health Care Survey released today. Enrollment in consumer-driven plans with a tax-advantaged account was 2 percent of the privately insured adults in 2007. One in 10 insured adults had high-deductible health plans (HDHPs) without accounts. The survey also found the percentage of consumer-driven plan enrollees with high incomes (above $100,000) swelled in 2007.

Consumer-driven plans were introduced in 2001 with the goal of decreasing the number of uninsured, encouraging cost-consciousness among consumers, and increasing the amount of information on the cost and quality of providers. The plans have been controversial because of criticism they favor wealthy and healthy participants at the expense of those with lower incomes and poorer health status.

Results of the survey appear in the March 2008 EBRI Issue Brief, available at http://www.ebri.org, and on the Commonwealth Fund Web site, http://www.commonwealthfund.org. The EBRI/Commonwealth survey found differences in the types of people enrolled in the various health plans. Consumer-driven plan enrollees are in better health, are less likely to smoke, are more likely to exercise, and to be white, male, and higher-income. They are no more likely to have been uninsured prior to enrollment than adults in other plans. In terms of behavior, enrollees in consumer-driven plans are more cost-conscious about their health care than are people enrolled in more comprehensive plans, are less satisfied with their plans overall, and are more likely to
'/>"/>

SOURCE Employee Benefit Research Institute
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Experimental Biology 2008 Todays Research: Tomorrows Health, April 5-9
2. Manhattan Research: ePharma Consumer(R) Research and Advisory Service Now Available
3. Enrollment completed in 2 pivotal phase III studies of the investigational cancer drug vandetanib
4. Hyperion Therapeutics Announces Enrollment of First Patient in Phase 2 Clinical Trial in Patients With Hepatic Encephalopathy
5. New 2008 Health Plan Directory Features Year-End 2007 Enrollment Data and 4,600 Key Executives
6. Office of Administration Extends Retired State Employees Health Benefits Enrollment Period to March 21
7. Medicares Drug Program Enrollment Up, Costs Down
8. MedicareCRM(TM) Simplifies Annual Enrollment Period for Medicare Health Plans and Beneficiaries
9. Boosts in Managed Care Enrollment Seen Across The Board
10. Devax Announces Completion of Enrollment of DIVERGE Trial of Novel Drug- Eluting Stent System for Bifurcation Lesions
11. Blue Cross Stop Smoking Phone Coaching Enrollments Jumped in October
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Last week, the Fed reported an ... Industrial production rose to 0.4% while manufacturing output progressed to ... single largest boost since February this year. Capacity use has ... as well – an increase that could be attributed to ... 79.2% rate, which is a measure of slack across the ...
(Date:8/29/2014)... India (PRWEB) August 29, 2014 Ethane ... has recently launched a new service named HTML web ... research based service. Before tailoring the service, Ethane Web ... by other companies. The company has done its best ... impeccable and able to deliver outstanding results to clients. ...
(Date:8/29/2014)... effect, stimulating neurite extension in the presence ... enhancing nerve regeneration following nerve crush injury ... to stimulate nerve regeneration is limited because ... hypertension, and its considerable cost. With long-term ... drugs reportedly cause life-threatening infections. Like FK506, ...
(Date:8/29/2014)... The Fresh Diet, America’s premier gourmet meal delivery ... meal plan. Originating from The Fresh Diet’s commitment to ... designed to satisfy customers seeking a convenient, worry-free option ... to the growing demand by customers for non-meat menu ... with 14% of Americans identifying vegetarian meals as ‘more ...
(Date:8/29/2014)... 2014 Glendale Botox experts at ... Botox throughout the month of September. This special offer features ... syringes of Juvederm. Patients can take advantage of this special ... Glendale Botox experts will work with patients to determine if ... What is Botox? , Botox is a treatment made ...
Breaking Medicine News(10 mins):Health News:LeaseQ Announces That Recent Industrial Production Report Spells Good Things For The Equipment Leasing Industry 2Health News:LeaseQ Announces That Recent Industrial Production Report Spells Good Things For The Equipment Leasing Industry 3Health News:Ethane Web Technologies Launches a New Web Design Service 2Health News:The Fresh Diet America's #1 At-Home Meal Delivery Company, Debuts Fresh Vegetarian Meal Plan Offering All-Natural Ingredients 2Health News:The Fresh Diet America's #1 At-Home Meal Delivery Company, Debuts Fresh Vegetarian Meal Plan Offering All-Natural Ingredients 3Health News:Glenoaks Laser Center is Now Offering a Special Promotion on Botox for the Month of September 2
... New personalized service educates clients about Medicare; identifies best options ... , ... Belleville, Ill. (Vocus) September 10, ... expanding the services it offers to individuals with disabilities with ...
... PARSIPPANY, N.J., Sept. 10 DSM Pharmaceutical ... Nice LLC as agency of,record for marketing ... covers services for this DSM business group ... DSM Biologics and DSM Pharmaceuticals, Inc., ...
... 10, 2008)In recent years, private equity investors have ... by investigative reports and anecdotal evidence that these ... companies have found themselves under increased federal scrutiny. ... such conclusions may be premature. Private equity purchases ...
... and C14-UBT are the most commonly used non-invasive tests of ... tests depend also on the prevalence of H. pylori ... the tests depend also on the prevalence of H. ... imply higher sensitivity and lower specificity. There are reports suggesting ...
... for people who support affordable health insurance options for American ... ... politicians dispense,their health care ideas at party conventions and local rallies, ... to do so is at,AffordableHealthInsurance.NET -- a new social network that ...
... Inc.,(Nasdaq: ENCO ), a full service multinational ... countries for many of the world,s,leading pharmaceutical and ... an amendment (the "Amendment") to its letter of ... the,Amendment, the Company will acquire all of the ...
Cached Medicine News:Health News:Allsup's New Medicare Advisor Program Helps People with Disabilities Make Sound Healthcare Coverage Decisions 2Health News:Allsup's New Medicare Advisor Program Helps People with Disabilities Make Sound Healthcare Coverage Decisions 3Health News:Allsup's New Medicare Advisor Program Helps People with Disabilities Make Sound Healthcare Coverage Decisions 4Health News:Allsup's New Medicare Advisor Program Helps People with Disabilities Make Sound Healthcare Coverage Decisions 5Health News:DSM Pharmaceutical Products Announces the Appointment of That's Nice LLC as Agency of Record for Marketing 2Health News:DSM Pharmaceutical Products Announces the Appointment of That's Nice LLC as Agency of Record for Marketing 3Health News:Private equity companies purchase nursing homes, but care does not suffer 2Health News:Private equity companies purchase nursing homes, but care does not suffer 3Health News:Social Network for Affordable Health Care Supporters Stimulates a New Level of Interactivity and Dialogue 2Health News:Prologue Acquisition Update and Termination of Linkcon Business Combination 2Health News:Prologue Acquisition Update and Termination of Linkcon Business Combination 3Health News:Prologue Acquisition Update and Termination of Linkcon Business Combination 4Health News:Prologue Acquisition Update and Termination of Linkcon Business Combination 5
(Date:8/29/2014)... -- Diseases largely eradicated in the United ... was declared eliminated in 2000, yet the CDC reports ... highest incidence in 20 years. In July, ... a problem of "epidemic proportions." ... these preventable diseases—in part because some parents (more than ...
(Date:8/29/2014)... YORK, Pa. , Aug. 29, 2014  Unilife ...  ASX: UNS) announced today that it intends to release ... and year ended June 30, 2014 after market trading ... Management has scheduled a conference call for 4:30 p.m. ... 10, 2014 at 6:30 a.m. AEST), to review the Company,s ...
(Date:8/29/2014)... , Aug. 29, 2014 /PRNewswire-iReach/ -- ChemImage will present ... Australian and New Zealand Forensic Science Society,s 22 ... in Adelaide, Australia .  Forensic ... the advancements that hyperspectral imaging can bring to ... Beckstead , Director of Product Development at ChemImage, ...
Breaking Medicine Technology:Vaccines at the Crossroads: Outbreaks On the Rise Across America 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 3Unilife Corporation to Announce Financial Results for Fiscal Year 2014 Fourth Quarter and Year End on Tuesday, September 9, 2014 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 3
... Anthera Pharmaceuticals,announced today they have reached agreement ... on a Phase 3 protocol for varespladib ... FDA,s Special Protocol Assessment,procedure. At the same ... European Medicines Agency (EMEA) on Anthera,s European ...
... Summary: Genmab has Completed Recruitment of Patients in the ... of Ofatumumab in Rituximab Refractory Follicular NHL, COPENHAGEN, ... has completed recruitment of patients in the,pivotal Phase III ... (NHL). Eighty-one patients,receiving treatment at the 1000 mg dose ...
Cached Medicine Technology:Anthera Completes Special Protocol Assessment With FDA and Receives EMEA Scientific Advice on Development Path Toward Varespladib Approval 2Anthera Completes Special Protocol Assessment With FDA and Receives EMEA Scientific Advice on Development Path Toward Varespladib Approval 3Recruitment Completed in Ofatumumab NHL Pivotal Study 2Recruitment Completed in Ofatumumab NHL Pivotal Study 3